US EditionPublished • loading... • Updated
GSK cutting jobs in UK and US as part of ongoing R&D changes
GSK will cut up to 350 research and development roles in the UK and US while increasing R&D investment by nearly 90% to £6.4 billion in 2024, the company said.
Summary by Evening Standard
2 Articles
2 Articles
Evening StandardReposted by 
perspectivemedia.com
perspectivemedia.comGSK cutting jobs in UK and US as part of ongoing R&D changes
It is understood around 50 UK jobs so far are being cut in the group’s main UK R&D hub in Stevenage, Hertfordshire.
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
